CD133 suppression increases the sensitivity of prostate cancer cells to paclitaxel.
Aghajani M, Mokhtarzadeh A, Aghebati-Maleki L, Mansoori B, Mohammadi A, Safaei S, Asadzadeh Z, Hajiasgharzadeh K, Khaze Shahgoli V, Baradaran B.
Aghajani M, et al. Among authors: mokhtarzadeh a.
Mol Biol Rep. 2020 May;47(5):3691-3703. doi: 10.1007/s11033-020-05411-9. Epub 2020 Apr 3.
Mol Biol Rep. 2020.
PMID: 32246247